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Abstract
Background: Pregnant women infected by the pandemic influenza A (H1N1) 2009 virus had more severe disease and higher
mortality but its pathogenesis is still unclear.
Principal Findings: We showed that higher mortality, more severe pneumonitis, higher pulmonary viral load, lower
peripheral blood T lymphocytes and antibody responses, higher levels of proinflammatory cytokines and chemokines, and
worse fetal development occurred in pregnant mice than non-pregnant controls infected by either wild type (clinical
isolate) or mouse-adapted mutant virus with D222G substitution in hemagglutinin. These disease-associated changes and
the lower respiratory tract involvement were worse in pregnant mice challenged by mutant virus. Though human placental
origin JEG-3 cell line could be infected and proinflammatory cytokines or chemokines were elevated in amniotic fluid of
some mice, no placental or fetal involvement by virus were detected by culture, real-time reverse transcription polymerase
chain reaction or histopathological changes. Dual immunofluorescent staining of viral nucleoprotein and type II alveolar cell
marker SP-C protein suggested that the majority of infected alveolar epithelial cells were type II pneumocytes.
Conclusion: The adverse effect of this pandemic virus on maternal and fetal outcome is largely related to the severe
pulmonary disease and the indirect effect of inflammatory cytokine spillover into the systemic circulation.
Citation: Chan K-H, Zhang AJX, To KKW, Chan CCS, Poon VKM, et al. (2010) Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe
Disease and Higher Mortality in Pregnant BALB/c Mice. PLoS ONE 5(10): e13757. doi:10.1371/journal.pone.0013757
Editor: Matthias G. von Herrath, La Jolla Institute of Allergy and Immunology, United States of America
Received July 25, 2010; Accepted October 13, 2010; Published October 29, 2010
Copyright:  2010 Chan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors are grateful to the support from the Ted Sun Foundation, the Clinical Infectious Diseases Research Endowment Fund from Ms. Teresa
Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, and the Research Grants Council of the Hong Kong Special
Administrative Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kyyuen@hkucc.hku.hk
. These authors contributed equally to this work.
Introduction
The pandemic influenza A(H1N1) 2009 virus caused similar
spectrum of illness as seasonal influenza virus except for more
severe diseases in younger adults with little cross-reactive
neutralizing antibody [1,2,3,4]. Besides extremes of age and
underlying medical illness, obesity and pregnancy were also
significant risk factors for severe infection by this pandemic virus
[5,6,7,8,9]. Pregnancy is a well-known risk factor for severe disease
in seasonal influenza [10]. Other viral infections, such as
chickenpox, have been shown to be more likely to cause fatality
in pregnant women than non-pregnant adults [11]. Despite many
reports on severe influenza in pregnancy, few immunological and
histopathological studies on its pathogenesis were performed.
Moreover reports on the virulence of this pandemic virus in mice
model were contradictory [2,12]. Recently we and others showed
that the substitution of glutamate by glycine at position 222 of the
viral hemagglutinin (D222G by H1 numbering or D225G by H3
numbering) was found to be significantly more frequent in patients
with severe pandemic influenza H1N1 [[13,14,15,16,17,18]. This
mutant virus often existed as quasispecies, and had increased
predilection for the lower respiratory tract [13]. Furthermore the
mutant virus was more virulent than the parental clinical isolate in
BALB/c mice [19]. To understand the pathogenesis of this novel
virus in pregnancy, we analyze the chemokine and cytokine
profiles, viral load and histopathological changes in placental cell
line and BALB/c mice infected by the wild type pandemic
influenza A(H1N1) 2009 virus, which is a clinical isolate from a
patient with mild disease, and a D222G mutant, which can cause
severe clinical outcome.
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Virus strains
The human clinical isolate influenza virus H1N1, HK/415742/09
(wild type) and mouse-adapted strain HK/415742/09-Mut, which
has a single D222G substitution in hemagglutinin (HA) gene, were
purified by plaque forming assay in Madin-Darby canine kidney
(MDCK) cells. The purified viruses were grown in embryonated eggs
for animal experiments and MDCK cells for cell culture experiments
as reported previously [19]. After titer determination, the cultured
viruses were aliquoted and kept at 280uC till use.
Virus-turkey erythrocyte binding assay
Virus-turkey erythrocyte binding assay was performed as
previously described with minor modifications [20]. Briefly, turkey
erythrocytes were treated with different concentrations of Vibrio
cholerae neuraminidase (Sigma, St. Louis, USA) for 60 min at 37uC
to remove the 2,3-linked sialic acid. The erythrocytes were washed
twice with phosphate buffered saline (PBS) and then diluted to 2%
(v/v) erythrocytes solutions with PBS. The 2% erythrocyte solution
(25 ml) was mixed with 8 HA unit of influenza viruses (100 ml) and
incubated at room temperature for 60 min. Hemagglutination was
measured and data expressed as the maximal concentration of
neuraminidase that allowed for full hemagglutination.
Viral infection in human placental cell line
The wild type and mutant viruses were inoculated into human
choriocarcinoma cell line JEG-3 (HTB-36, ATCC, Rockville,
MD) at 1 multiplicity of infection (MOI) per cell and incubated at
37uC. Supernatants were collected at 6, 24, 72 and 120 hours
post-infection for the determination of viral loads by real time
reverse-transcription polymerase chain reaction (RT-PCR) and
antigen expression by immunofluorescence method as reported
previously [21], while infected cells were harvested at 1, 3 and
6 hours post-infection for the detection of proinflammatory
cytokines and chemokines, by real time RT-PCR in triplicate for
each sample as reported previously [22].
Viral infection in pregnant and non-pregnant mice
Pregnant (11-weeks old) and age-matched non-pregnant female
BALB/c mice were kept in biosafety level-3 housing and given
access to standard pellet feed and water ad libitum. All
experimental protocols followed the standard operating proce-
dures of the approved biosafety level-3 animal facilities and were
approved by the Animal Ethics Committee (committee on the use
of live animals in teaching & research CULATR No. 1929_09)
[23]. Pregnant mice at the gestational ages of 12–14 days and non-
pregnant mice were intranasally inoculated with 2610
6 plaque
forming units (PFU) of wild type virus and 150 PFU of mutant
virus (Table 1), respectively, after anesthesia with ketamine
(100 mg/kg) and xylazine (10 mg/kg) by intraperitoneal injection.
Signs of the disease and survival were observed daily till day 21
post-infection. Eight (4 per experiment done in duplicate) mice per
group were sacrificed for collections of blood, lung, brain, kidney,
liver, spleen, placenta, fetus and amniotic fluid specimens at day 3
and 6 post-infection, respectively. For the pregnant groups, four
placentas and 4 fetuses were also collected from each pregnant
mouse, of which half were frozen immediately and the other half
were fixed in formalin for further study.
Viral titration and viral load detection
Titers of released virus in lung homogenates were determined
by plaque assays, whereas viral RNA in lung tissues, placenta and
foetus was quantified by real-time RT-PCR as reported previously
[19,23]. Plaque forming assays were not performed if real-time
RT-PCR is not negative for viral RNA.
Detections of cytokines and chemokines
Levels of pro-inflammatory cytokines and chemokines in lung
homogenates, serum and amniotic fluid were determined by
ELISA as described previously [19,23]. The samples were also
collected from uninfected pregnant and non-pregnant mice as
negative controls.
Histopathological examinations
Mouse lung, brain, kidney, liver, spleen, placenta and fetus were
immediately fixed in 10% formalin after sampling and embedded
in paraffin. Tissue sections of 5 mm were stained with hematoxylin
and eosin (H&E) [23]. Expression of influenza A viral nucleopro-
tein (NP) in lung, placenta and fetal tissues was examined by
immunohistochemical staining. The tissue sections were depar-
affinized and rehydrated, followed by blocking with 1% bovine
serum albumin in PBS to minimize non-specific staining. The
sections were incubated with mouse anti-influenza nucleoprotein
monoclonal antibody (HB65, ATCC) at 1:5000 dilution overnight
at 4uC. After washing for 3 times with PBS, the sections were
incubated with a secondary antibody with biotin conjugated goat
anti-mouse IgG (Calbiochem, Darmstadt, Germany) at 1:2000
dilution for 30 minutes at room temperature. Streptavidin/
peroxidase complex reagent (Vector Laboratories, Burlingame,
CA, USA) was then added and incubated at room temperature for
30 min. Color development was performed with diaminobenzi-
dine (DAB, Vector Laboratories, Burlingame, CA, USA) and the
images were captured by Nikon 80i imaging system with Spot-
advance computer software. To determine the type of virus
infected cells in mouse lung alveoli, viral NP protein and type II
alveolar cell marker SP-C protein were examined for their co-
localization within the infected cells. Briefly, after blocking with
1% bovine serum albumin in PBS, the tissue sections were
incubated with a mixture of mouse anti-influenza nucleoprotein
monoclonal antibody and rabbit anti-mouse SP-C antibody (Santa
Cruz Biotechnology, Santa Cruz, CA USA) at 1:200 dilution.
Table 1. Viral challenge and sample collections in pregnant and non-pregnant mice.
Challenge by wild type virus Challenge by mutant virus
Total numbers Survival observation Sampling numbers Total numbers Survival observation Sampling numbers
Pregnant 24 8 16 25 9 16
Non-pregnant 25 9 16 25 9 16
Four groups of the mice (12-13 mice/group) were intranasally inoculated with wild type or mutant viruses. Four groups of mice were sampled at day 3 and 6 post-
infection, respectively. The experiment was duplicated. This table showed the total numbers of mice in these two experiments.
doi:10.1371/journal.pone.0013757.t001
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conjugated donkey anti-rabbit IgG and FITC conjugated donkey
anti-mouse IgG (JacksoniImmunoResearch, West Grove, PA,
USA) were then added and incubated at room temperature for
30 min. The sections were mounted in vectashield mounting
medium with DAPI and analyzed under Nikon 80i fluorescent
microscope imaging system with Spot-advance computer software.
Peripheral T lymphocyte count and antibody level
Peripheral T cells in heparinized blood samples collected on day 3
and day 6 post-infection from infected and non-infected mice were
stained with fluorescein-labeled anti-mouse CD3 (Cy5), CD4 (FITC)
and CD8a (PE) monoclonal antibodies (BioLegend, San Diego) and
fixed with 4% p-formaldehyde overnight. The fixed blood cells were
analyzed by flow cytometer (FACSCaliber, BD, USA) and the serum
antibody level was detected as described previously [23].
Statistical Analysis
Survival of mice was analyzed by the Kaplan-Meier method
and Log-rank test using SPSS 17.0 for Windows (SPSS Inc.,
Chicago, IL), whereas viral load, cytokine and chemokine profiles
were calculated by Student’s t-test. Results were considered
significant at P,0.05. Results of the virus-turkey erythrocyte
binding assay was analyzed by one-way ANOVA using the mean
square in the ANOVA to estimate of variability.
Results
Infection of placental cell line by both clinical isolate and
mouse adapted mutant viruses
Two isolates were used in this study. One isolate, HK/415742/
09, was characterizedfrom the first patientwith pandemic influenza
A(H1N1) 2009 virus infection in Hong Kong in May 2009 [24] and
the other isolate was a mutant virus, HK/415742/09-Mut after
mouse adaptation of the clinical isolate. Mouse adapted virus was
found to have increased virulence in mice [19]. Genetic analysis of
mutant virus found that change of virulence may be attributed to
the D222G substitution in the HA gene. In a binding assay using
turkey erythrocytes treated with neuraminidase which mainly
removed 2,3-linked sialic acids, a 32-fold higher concentration of
neuraminidase was necessary to inhibit the hemagglutination of
turkey erythrocytes by wild type virus as compared to mutant virus
(Fig. 1). The results suggested that the mutant virus preferably binds
to a-2,3 linked sialic acid receptor, a receptor of influenza A virus
which is more abundantly expressed in lower respiratory tract.
A placental cell line, JEG-3 cells, derived from human
choriocarcinoma, was used to examine infection and replication
of the pandemic H1N1 virus. Our results showed that JEG-3 cells
can be infected by both wild type and mutant viruses (Fig. 2A).
Though no obvious cytopathic effects appeared after more than 5
days of cultures, viral load in culture supernatant increased about
2.5 logs for both wild type and mutant viruses after 24 hours of
infection (Fig. 2B). Proinflammatory cytokine and chemokine gene
expressions increased 0.5 to 6 folds from baseline levels at 6 hours
post-infection (Fig. 2C). Cox 2 gene was highly induced by the
mutant virus when compared with the wild type. The results
suggest a potential of this virus in causing infection and
inflammation of the placenta in human.
Infected pregnant mice exhibited significantly higher
mortality
Intranasal inoculation with 2610
6 PFU of wild type virus did
not cause lethal infection in non-pregnant BALB/c mice (Fig. 3).
Although infected mice showed ruffled fur and labored breathing
for a few days, they later recovered and survived for 21 days. In
contrast, when pregnant mice were challenged with the same dose
of wild type virus, only 62.5% of infected pregnant mice survived,
with a mean survival time of 17 days. In another challenge
experiment, intranasal inoculation of 150 PFU of mutant virus
caused 44.4% and 100% death in non-pregnant mice and
pregnant mice, respectively. These results showed that either low
pathogenic wild type virus or highly pathogenic mutant virus
carrying a D222G substitution in HA [19] resulted in significantly
higher mortality in pregnant mice than in non-pregnant mice
(P,0.001).
Infected pregnant mice showed higher levels of viral
replication in the lungs
Viral titers (Fig. 4A) and viral loads (Fig. 4B) in lung
homogenates of mice infected by wild type were significantly
higher in pregnant mice than in non-pregnant mice at day 3 post-
infection (P,0.01). Furthermore, viral loads in lung tissues of both
pregnant and non-pregnant mice infected with the mutant virus
were also significantly higher than those infected by wild type virus
(P,0.05, Fig. 4A & 4B) consistent with our previous report that
D222G mutant is more likely to replicate in the lower respiratory
tract tissues [19]. No evidence of viral infection was found in brain,
liver, kidney, spleen, placenta and fetus by quantitative RT-PCR
(data not shown).
Figure 1. Virus-turkey erythrocyte receptor binding avidity
assay. Influenza virus cellular receptor binding affinity was tested with
turkey erythrocytes pre-treated with Vibrio cholerae neuraminidase
which mainly removes 2, 3-linked sialic acids as described in the
Materials and Methods. A) Illustration of assay for receptor binding
avidity. B) Receptor binding avidity of mut and wt viruses. Data are
representative of three independent experiments. Data was analyzed by
one-way ANOVA using the mean square in the ANOVA to estimate of
variability. P-value,0.001. PR8, A/Puerto Rico/8/34; Mut, mutant virus;
WT, wild type virus.
doi:10.1371/journal.pone.0013757.g001
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viral NP was expressed mainly in bronchial and alveolar epithelial
cells (Fig. 4C). The number of NP positive cells was much lower in
non-pregnant mice infected with both wild type (Fig. 4Ca) and
mutant (Fig. 4Cc) than in infected pregnant mice (Fig. 4Cb & Cd).
NP positive cells were more abundant in lungs from mice infected
by mutant virus (Fig. 4Cc & Cd) than that of mice infected by wild
type virus (Fig. 4Ca & Cb). These findings are consistent with the
histological severity of pneumonitis in infected mice. Furthermore,
in mice infected with wild type virus, NP positive cells were mainly
distributed in bronchial epithelial cells and just a few sporadic
alveolar cells (Fig. 4Ca & Cb). While with mutant virus infection,
abundant NP positive alveolar cells were found in addition to the
positive bronchial epithelial cells (Fig. 4Cc & Cd). Morphologi-
cally, most NP positive alveolar cells were type II pneumocytes
with occasional type I pneumocytes (Fig. 4Ce). Dual immunoflu-
orescent staining of viral NP and type II pneumocyte marker SP-C
protein indeed confirmed that most of the NP positive pneumo-
cytes were type II cells (Fig. 4Cf).
Infected pregnant mice exhibited more severe
pneumonia
Interstitial pneumonitis with alveolar exudation and interstitial
infiltration were seen in all infected mice (Fig. 5), but the severity
of the damages in the lungs varied remarkably between pregnant
and non-pregnant mice. With wild type virus infection, mild
bronchitis and foci of thickened alveolar walls with unaffected
normal alveolar structure were found in non-pregnant mice
(Fig. 5Aa), whereas moderately severe alveolitis with exudation,
leukocytic infiltration and alveolar damage were found in
pregnant mice infected by wild type virus (Fig. 5Ab). Again, it
was found that much more severe necrotizing bronchitis, large
areas of pulmonary consolidation with inflammatory cell
infiltrates and moderate-to-severe pulmonary edema were found
Figure 2. Viral infection in JEG-3 cells. A. Direct immunofluorescent staining of JEG-3 cell lines using anti-influenza nucleoprotein (NP) antibody
showed viral NP expression in wild type virus-infected cells (a), but not in negative control of uninfected cells (b). B. Viral load (viral RNA copies/ml)
determined by real-time RT-PCR and percentage of JEG-3 cells with immunofluorescent stained viral NP after infection by wild type (WT) or mutant
(Mut) virus were shown. Error bar indicates 6 standard deviation (SD) from triplicate experiments. C. Pro-inflammatory cytokine and chemokine
expressions in JEG-3 cells infected with wild type or mutant virus determined by real-time RT-PCR at indicated time-points. Error bar indicates 6 SD
from 3 different experiments. TNF-a: tumor necrosis factor-a; IFN-c: interferon-c; IL-6: interleukin-6, Cox-2: cyclooxgenase 2; MCP-1: monocyte
chemotactic protein-1.
doi:10.1371/journal.pone.0013757.g002
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their survivals were recorded in indicated days. ** indicates significant difference (P,0.001) between pregnant and non-pregnant mice.
doi:10.1371/journal.pone.0013757.g003
Figure 4. Viral infection and replication in lungs. A. Virus titers in lung homogenates collected from mice infected with wild type (WT) or
mutant (Mut) virus on indicated days post-infection were measured by plaque forming assay. ** indicates significant differences (P,0.001) between
pregnant and non-pregnant mice. B. Viral RNA copies in the same lung homogenates were also determined by real-time RT-PCR. * indicates
significant differences (P,0.001) between pregnant and non-pregnant mice. C. Immunohistochemical staining for influenza viral nucleoprotein (NP)
protein in lung sections of infected mice. Representative images of lung sections from wild type virus infected bronchial epithelium of non-pregnant
(a) and pregnant (b) mice, and mutant virus infected alveoli of non-pregnant (c) and pregnant (d) mice. Original magnification: 1006. The NP positive
cells were morphologically identified to be type I alveolar cells (few) indicated by arrow heads and type II alveolar cells (majority) indicated by arrows
(e). Original magnification: 2006. Dual-labeling of mouse lung type II alveolar cells with anti-NP antibody conjugated with FITC and anti-SP-C
antibody conjugated with Texas red further confirmed that the virus mainly infected type II alveolar cells (f). Arrows indicates NP and SP-C double
positive alveolar cells. Original magnification: 4006.
doi:10.1371/journal.pone.0013757.g004
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(Fig. 5Ad) than in non-pregnant mice (Fig. 5Ac) infected by
mutant virus.
Pathological changes in other organs of infected
pregnant mice
No significant pathological changes were observed in brains
and spleens of infected mice (data not shown). Mild cell and tissue
injuries, mainly in forms of cellular edema and degeneration,
were found in liver (Fig. 5B) and kidney (Fig. 5C) from mice
infected with the mutant virus. The most severe tissue damage
was seen in mutant virus infected pregnant mice which exhibited
diffuse edema, degeneration and focal necrosis of hepatocytes
(Fig. 5Bd) and degeneration of renal tubular epithelial cells in
kidney (Fig. 5Cd). Similar but milder liver and kidney damages
were also present in wild type virus infected pregnant mice
(Fig. 5Bb & Cb), but they were not observed in non-pregnant
mice infected by either wild type (Fig. 5Ba & c) or mutant virus
(Fig. 5Ca & c).
Elevated levels of pro-inflammatory cytokines and
chemokines in lung homogenates
To study whether the severity of pneumonitis was associated
with elevated pro-inflammatory cytokines and chemokines in
infected pregnant mice, levels of interleukin-1b (IL-1b),
interleukin-6 (IL-6), interferon-c (IFN-c), macrophage inflam-
matory protein (MIP)-1a, MIP-2 and tumor necrosis factor-a
(TNF-a) in the lung homogenates of infected mice were tested
by ELISA. Elevated levels of pro-inflammatory cytokine and
chemokine in the lung homogenates were observed in the virus
infected mice as compared to the mock-infected control on day 3
post-infection (Fig. 6). Compared to non-pregnant mice,
significantly higher levels of IL-1b,M I P - 1 a and MIP-2 were
detected in pregnant mice infected with wild type virus
(P,0.03), while levels of IL-6, MIP-1a and MIP-2 were elevated
significantly in pregnant mice infected by mutant virus
(P,0.02). Notably, level of IFN-c was significantly lower in
pregnant mice than in non-pregnant mice (P,0.05), whereas
TNF-a level was similar between pregnant and non-pregnant
mice, whether they were infected by wild type or mutant virus.
Similar profiles of cytokine and chemokine responses to the
infection were also found in serum samples collected at day 3
post-infection (data not shown).
Impaired T cell and antibody responses in pregnant mice
Compared to uninfected mice, numbers of CD3+/CD4+
(Fig. 7A) and CD3+/CD8+ (Fig. 7B) peripheral blood T
lymphocytes were significantly lower in mice either infected with
wild type or mutant virus (P,0.0001). Levels of these T
lymphocytes were also significantly lower in pregnant than in
non-pregnant mice infected with wild type virus at day 3 post-
infection (P,0.001). Besides cellular immunity, specific antibody
titers in survived pregnant mice were also significantly lower than
that of surviving non-pregnant mice (Fig. 7C). These results
suggest that both cellular and adaptive humoral immune responses
are impaired in pregnant mice.
Figure 5. Histopathological changes in lungs, livers and kidneys of infected mice. Representative H&E stained sections showing changes in
lung, liver and kidney tissues of mice infected with wild type (a & b) or mutant virus (c & d). A. Various degrees of interstitial bronchitis, epithelial
necrosis, alveolitis and alveolar edema were found in lung tissues. B. Various degrees of degeneration were shown in liver cells. C. Degeneration of
renal tubular epithelial cells was found in kidney tissues. Original magnification: 2006.
doi:10.1371/journal.pone.0013757.g005
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and fetal tissues of infected pregnant mice
In mutant virus infected pregnant mice, at day 3 post-infection
(corresponding to gestational date 16–18 days), patchy necrosis of
placental trophoblast was found in all 13 placentas from 8
pregnant mice examined (Fig. 8Aa). Trophoblast apoptosis as
evidenced by apoptotic bodies was also detected (Fig. 8Ab).
Similar lesions were found at day 6 post-infection (data not shown).
In wild type virus infected mice, these changes were present but
mild. Smaller foci of necrosis and scattered apoptotic cells were
found in 7 of the 15 placentas examined (Fig. 8Ac and d), often
located in the junctional zone. However, all these histological
changes were not detected in the placental tissue from non-
infected control mice (Fig. 8Ae & f).
Histopathologicalexaminationoffetaltissuesfrompregnantmice
infected with mutant virus at day 3 and day 6 post-infection showed
various degrees of pulmonary congestion (Fig. 8Ba) and myocardial
degeneration (Fig. 8Bc). Multiple foci of necrosis were found in fetal
liver tissues (Fig. 8Be). These pathological changes were not obvious
in mice infected with wild type virus (Fig. 8Bb, d & f).
Compared with uninfected pregnant mice, no significant
changes of cytokine and chemokine levels was found in the
amniotic fluid collected at day 3 post-infection (data not shown),
whereas marked elevations of MIP-1a and MIP-2 were detected in
mutant virus infected pregnant mice at day 6 post-infection
(Fig. 8C). Mutant virus infection of pregnant mice also affected the
development of fetus as evidenced by the smaller size of the fetus
(Table 2). At day 3 post-infection (16–18 days of gestation), the
Figure 6. Proinflammatory cytokines and chemokines in lung homogenates. Proinflammatory cytokines and chemokines in lung
homogenates collected from wild type (WT) or mutant (Mut) virus infected mice at day 3 post-infection and uninfected mice (Ctl) were detected by
ELISA. ** indicates significant differences (P,0.001) and * indicates significant differences (P,0.05) between pregnant and non-pregnant mice. IL-1b:
interleukin-1b, IL-6: interleukin-6, IFN-c: interferon-c, MIP-1a: macrophage inflammatory protein 1a, MIP-2: macrophage inflammatory protein 2; TNF-
a: tumor necrosis factor-a.
doi:10.1371/journal.pone.0013757.g006
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mice was 0.55 6 0.14 g, which was significantly lighter than the
average weight of fetuses (0.66 g 6 0.15 g ) from the wild type
infected mice (P,0.05). At day 6 post-infection (gestation days 19–
21), none of the mutant virus infected pregnant mice gave birth.
The fetuses removed at day 6 had an average body weight of 0.77
6 0.19 g, which was significantly lower than that of wild type
infected pregnant mice (1.09 6 0.06 g, P,0.001). All wild type
virus infected mice gave birth at the end of gestational date and all
newborns appeared normal. Furthermore, no gross morphological
changes that indicated teratogenic effects on fetal development
were found in the fetus from mutant virus infected mice.
Discussion
While generally mild for most patients, the pandemic influenza
A(H1N1) 2009 virus cause disproportionately more severe
outcome in pregnant women. Since replication of this pandemic
influenza virus can occur in placenta originated JEG-3 cells, a
pregnant BALB/c challenge model was established to study the
temporal virological, immunological and histopathological chang-
es. Since differential severity caused by genetic variants of the
pandemic H1N1 virus has been reported [13,14,15,17,18], we
compare disease severity associated with different phenotypic
strains by using one clinical isolate which causes relatively mild
disease, and its mouse adapted mutant virus which is able to cause
much more severe disease and even fatal outcome in mice.
Challenge of pregnant mice with the same viral inoculum caused
more severe interstitial pneumonitis and higher mortality than the
non-pregnant controls with either wild type or mouse adapted
mutant virus. These findings corroborated with higher rates of
hospitalization, ICU admission for severe disease and mortality in
pregnant women than the general female population [7]. As
expected from findings of our previous study [19], the D222G
mutant virus was also more virulent for pregnant mice. Though
some previous studies suggested teratogenic effects in human [25],
chick and mouse embryos exposed to influenza B [26] and
reduction of cortical matter in pregnant Rhesus monkeys [27], no
gross teratogenicity was observed in our cohort of mice.
A switch of T lymphocyte helper immune function from Th1 to
Th2 which induces a state of relative immunosuppression to
prevent rejection of the fetus during pregnancy was hypothesized
[28] to explain the severe illness in human pregnancy. Indeed
extrapulmonary and fetal infection was demonstrated in pregnant
women infected by seasonal influenza A H3N2 and avian
influenza A H5N1 viruses [29,30]. Though the human placental
cell line JEG-3 can be infected by this pandemic virus with
increased expression of cytokine and chemokines, no evidence of
extrapulmonary dissemination of virus was detected by viral
culture or quantitative RT-PCR in our mouse model challenged
by wild type or mouse adapted mutant with the D222G mutation.
Similar to most previous studies in human pregnancy, florid
inflammatory damage in the lungs was associated with marked
increase in proinflammatory cytokines and chemokines in our
pregnant mice model. Levels of cytokines and chemokines that
mainly reflected inflammatory responses such as MIP-1a, MIP-2,
IL-1b or IL-6, were significantly worse in infected pregnant mice,
while those markers indicating not only inflammatory but also
antiviral immune responses such as TNF-a and IFN-c, were
similar or even significantly lower in pregnant mice as compared
to non-pregnant mice. The spillover of some of these pro-
inflammatory cytokines or chemokines from the lungs was evident
paralleled by similar increase in their levels in the serum and
amniotic fluid. Thus the involvement of the placenta and fetus as
evident by placenta cell necrosis and apoptosis, and fetal tissue
degeneration were just manifestations of the severe systemic
inflammatory response syndrome and hypoxia due to respiratory
failure rather than the effect of extrapulmonary viral replication
Figure 7. Detection of blood T cell levels and antibody
response. A. CD3+/CD4+ and B. CD3+/CD8+ T lymphocytes were
detected in blood samples collected from wild type (WT) or mutant
(Mut) virus infected mice at indicated days post-infection and
uninfected control mice (Ctl). Compared to uninfected mice, numbers
of CD3+/CD4+ and CD3+/CD8+ peripheral blood T lymphocytes were
significantly lower in mice either infected with wild type or mutant virus
(P,0.0001). C. Levels of antibodies were detected in serum samples
collected from infected mice at indicated days post-infection by HI
assay. ** indicates significant differences (P,0.001) and * indicates
significant differences (P,0.02) between pregnant and non-pregnant
mice. Serum samples from 10 non-pregnant and 10 pregnant collected
on day 6, and from 14 non-pregnant and 6 pregnant mice on day 21,
were tested for antibody.
doi:10.1371/journal.pone.0013757.g007
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PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13757Figure 8. Pathological and immunological changes in placenta and fetus. A. Placentas collected from pregnant mice infected with mutant
(a & b) or wild type (c & d) virus at day 3 post-infection were examined after H&E staining. a, ** indicated large area of necrosis, c, * indicated two
smaller foci of necrosis in the junctional zone of the placenta. Arrows in b &d indicated apoptotic bodies and nuclear debris in the trophoblast. e & f
are placentas from uninfected control mice showing no significant pathological changes. Magnification of a, c, e & f 200x and b & d 400x. B.
Representative sections from fetal lung (a), myocardium (c) and liver (e) tissues from mutant virus infected mice but not obvious in wild type virus
infected mice (b, d & f). Original magnification: 2006. C. Levels of indicated cytokines and chemokines in amniotic fluids collected from mice infected
with wild type (WT) or mutant (Mut) virus and uninfected mice (Ctl) were detected by ELISA. * indicates significant differences (P,0.05) between
pregnant mice infected with wild type and mutant viruses. IL-1b: interleukin-1b, IL-6: interleukin-6, IFN-c: interferon-c, MIP-1a: macrophage
inflammatory protein 1a, MIP-2: macrophage inflammatory protein 2; TNF-a: tumor necrosis factor-a.
doi:10.1371/journal.pone.0013757.g008
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from human placental or fetal specimens up to this time. Another
important determinant of severity in human influenza infection is
the inability of the host to control the viral load [3,31]. Previous
study showed a lower serum IgG2 in pregnant women affected by
severe pandemic influenza [32]. In our study, the highest viral load
and mortality were found in pregnant mice infected with mutant
virus which was associated with lower peripheral blood T
lymphocytes and hemagglutination inhibitory antibody titer.
The higher virulence of mouse adapted mutant virus in both
pregnant and non-pregnant mice than the wild type virus were
explained by the turkey erythrocyte binding assay which showed
that the mouse adapted virus with D222G mutation has a much
stronger avidity of binding to sialic acid with 2,3 linkage to
galactose. Such 2,3-linked sialic acid receptors are highly
abundant in the upper and lower respiratory tree of mice [33]
and relatively abundant in the lower respiratory tree of human.
The finding corroborated with the higher rate of detection of this
mutant in severe cases of pandemic influenza 2009 in human and
especially in their lower respiratory tract specimens. Though
seasonal influenza A virus tends to infect type I pneumocyte in
human, this pandemic virus tends to infect type II pneumocyte in
our mouse model. The significance of this finding remains to be
determined.
In summary, the detrimental effect of pandemic influenza virus
in pregnant mice mainly relies on the viral replication and
associated inflammation in the lungs which increased proinflam-
matory cytokine and chemokines in the systemic circulation and
amniotic fluid with no evidence of extrapulmonary viral
dissemination in our model even when a D222G mouse adapted
mutant virus was used.
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